Invention Grant
- Patent Title: Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
-
Application No.: US17156146Application Date: 2021-01-22
-
Publication No.: US11744847B2Publication Date: 2023-09-05
- Inventor: Geoffrey Paul Horst , Robert Bernard Levine
- Applicant: KEMIN INDUSTRIES, INC.
- Applicant Address: US IA Des Moines
- Assignee: KEMIN INDUSTRIES, INC.
- Current Assignee: KEMIN INDUSTRIES, INC.
- Current Assignee Address: US IA Des Moines
- Agency: NYEMASTER GOODE P.C.
- Main IPC: A61K31/716
- IPC: A61K31/716 ; A61K45/06 ; A61K35/68 ; A61K9/14 ; A61K33/30 ; A61K39/39 ; A23L33/125 ; A61P37/04 ; A61P39/00 ; A61P3/00 ; A61P3/06 ; A61P31/04 ; A61P1/00 ; A61K39/00
Abstract:
The present application relates to beta-1,3-glucan and uses thereof to modulate immunity in the human body. Also provided are methods for treatment and/or prevention of high cholesterol, diabetes, and allergies. Also provided are methods for treatment and/or prevention of intestinal inflammation.
Public/Granted literature
- US20210346423A1 USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION Public/Granted day:2021-11-11
Information query
